Important imaging studies (CT scan severity score) and changes in specific biomarkers levels, especially ferritin and C-reactive protein, were also noted and should be further investigated in correlation with the pathophysiological mechanisms of AKI progression in COVID-19 patients. This evidence concerns the gene CRP and COVID-19.